Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:ANZ CVE:GGL CVE:MEX NASDAQ:PBM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZSilver North ResourcesC$0.04C$0.04C$0.02▼C$0.06C$4.77M0.7150,724 shs72,000 shsGGLGGL ResourcesC$0.06-8.3%C$0.06C$0.03▼C$0.08C$5.05M1.1244,587 shs3,000 shsMEXMexican Gold MiningC$0.06-7.7%C$0.06C$0.03▼C$0.13C$1.27M1.1834,995 shs42,000 shsPBMPsyence Biomedical$2.36-53.1%$5.43$2.36▼$345.00$2.86M0.221.94 million shs2.31 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZSilver North Resources0.00%0.00%0.00%0.00%0.00%GGLGGL Resources-8.33%0.00%-15.38%-8.33%+37.50%MEXMexican Gold Mining0.00%0.00%+33.33%+9.09%-29.41%PBMPsyence Biomedical-53.08%-79.48%-58.23%-31.77%-99.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANZSilver North ResourcesN/AN/AN/AN/AN/AN/AN/AN/AGGLGGL ResourcesN/AN/AN/AN/AN/AN/AN/AN/AMEXMexican Gold MiningN/AN/AN/AN/AN/AN/AN/AN/APBMPsyence Biomedical1.5359 of 5 stars0.05.00.00.02.41.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZSilver North Resources 0.00N/AN/AN/AGGLGGL Resources 0.00N/AN/AN/AMEXMexican Gold Mining 0.00N/AN/AN/APBMPsyence Biomedical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZSilver North ResourcesC$71.7366,515.69C$0.00 per share15.00C$0.17 per share0.24GGLGGL ResourcesN/AN/AC$0.02 per share2.67C$0.06 per shareN/AMEXMexican Gold MiningN/AN/AC$0.00 per share20.00C$0.00 per shareN/APBMPsyence BiomedicalN/AN/A$0.84 per share2.81$11.83 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZSilver North Resources-C$6.65M-C$0.02N/A∞N/A-9,274,950.00%-34.32%-11.43%N/AGGLGGL Resources-C$1.88M-C$0.01N/A∞N/AN/A-7.49%-4.74%N/AMEXMexican Gold Mining-C$380.72K-C$0.02N/A∞N/AN/A-160.64%-60.82%N/APBMPsyence Biomedical$1.01MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANZSilver North ResourcesN/AN/AN/AN/AN/AGGLGGL ResourcesN/AN/AN/AN/AN/AMEXMexican Gold MiningN/A6.02%N/AN/AN/APBMPsyence BiomedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANZSilver North ResourcesN/A1.340.86GGLGGL Resources1.122.2115.34MEXMexican Gold MiningN/A2.561.92PBMPsyence BiomedicalN/A11.0411.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZSilver North Resources4.25%GGLGGL ResourcesN/AMEXMexican Gold MiningN/APBMPsyence Biomedical77.44%Insider OwnershipCompanyInsider OwnershipANZSilver North Resources23.40%GGLGGL Resources52.50%MEXMexican Gold Mining3.44%PBMPsyence Biomedical3.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZSilver North ResourcesN/A119.28 millionN/ANot OptionableGGLGGL ResourcesN/A91.86 millionN/ANot OptionableMEXMexican Gold MiningN/A21.23 millionN/ANot OptionablePBMPsyence BiomedicalN/A570,000548,000N/AMEX, GGL, PBM, and ANZ HeadlinesRecent News About These CompaniesPacific Bay Warrant Extension Not ProceedingAugust 1 at 6:11 PM | newsfilecorp.comNPsyence Biomedical stock soars after partner achieves ibogaine breakthroughAugust 1 at 2:35 AM | za.investing.comPsyence Biomedical Shares Soar 70% Following Partner’s Ibogaine Extraction BreakthroughAugust 1 at 2:35 AM | msn.comPsyence BioMed’s Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine ProductionJuly 31 at 7:45 AM | financialpost.comFPsyence BioMed's Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine ProductionJuly 31 at 7:30 AM | globenewswire.comPSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common SharesJune 25, 2025 | globenewswire.comPsyence Biomedical regains Nasdaq compliance after reverse splitJune 18, 2025 | investing.comPSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common SharesJune 18, 2025 | globenewswire.comPsyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025June 18, 2025 | newsfilecorp.comNPsyence Biomedical Ltd.: Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing RequirementsJune 17, 2025 | finanznachrichten.dePsyence Biomed Regains Full Compliance with NASDAQ Continued Listing RequirementsJune 17, 2025 | newsfilecorp.comNCVS Sues Arkansas Over Law Banning PBM Ownership Of PharmaciesMay 29, 2025 | forbes.comPsyence BioMed Finalizes Agreement with Award-Winning CRO Southern Star Research to Accelerate Phase IIb Clinical TrialMay 27, 2025 | newsfilecorp.comNPsyence Biomedical Ltd. WtMay 21, 2025 | marketwatch.comPsyence Biomedical Advances Psilocybin Drug Development as of May 2025May 20, 2025 | tipranks.comPsyence Biomedical announces reverse stock splitMay 2, 2025 | investing.comPsyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock SplitMay 1, 2025 | newsfilecorp.comNPsyence Group consolidates its sharesApril 18, 2025 | greenmarketreport.comGPsyence BioMed gets Nasdaq notice for non-complianceApril 18, 2025 | msn.comPsyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyApril 17, 2025 | newsfilecorp.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendA Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3By Thomas Hughes | July 24, 2025View A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3Chipotle: Too Spicy for Smart Money to Resist After Stock SplitBy Jeffrey Neal Johnson | July 11, 2025View Chipotle: Too Spicy for Smart Money to Resist After Stock SplitIs J.B. Hunt Stock a Sleeping Giant Heading Into 2026?By Thomas Hughes | July 19, 2025View Is J.B. Hunt Stock a Sleeping Giant Heading Into 2026?Warehouse Wars: Can BJ’s Take Advantage of Costco’s Weakness?By Dan Schmidt | July 7, 2025View Warehouse Wars: Can BJ’s Take Advantage of Costco’s Weakness?MEX, GGL, PBM, and ANZ Company DescriptionsSilver North Resources CVE:ANZC$0.04 0.00 (0.00%) As of 08/11/2023Alianza Minerals Ltd., an exploration stage company, acquires and explores mineral properties. The company explores for gold, copper, silver, zinc, molybdenum, and lead deposits. The company's primary asset is the Haldane silver/lead/zinc exploration project located in Yukon Territory; and holds interests in other gold, silver, and base metal projects located in Colorado, Nevada, and Peru. The company was formerly known as Tarsis Resources Ltd. and changed its name to Alianza Minerals Ltd. in April 2015. Alianza Minerals Ltd. was incorporated in 2005 and is based in Vancouver, Canada.GGL Resources CVE:GGLC$0.06 -0.01 (-8.33%) As of 08/1/2025 11:44 AM EasternGGL Resources Corp. engages in the acquisition, exploration, and evaluation of mineral properties in Canada and the United States. It explores for gold, copper, and silver deposits, as well as diamonds. The company holds interests in the McConnell Creek project located in the Omineca Mining Division of British Columbia; the Providence Greenstone Belt located in the northeast of Yellowknife, Slave Craton; and the Nevada Lithium project consists of various lithium sediment bearing mining claims in Nevada. It also has an option to acquire interest in Gold Point Project located in Nevada; and the Stein Diamond Project located in Southern Boothia Peninsula. GGL Resources Corp. was incorporated in 1981 and is headquartered in Vancouver, Canada.Mexican Gold Mining CVE:MEXC$0.06 -0.01 (-7.69%) As of 07/31/2025 12:03 PM EasternMexican Gold Mining Corp., a mineral exploration company, engages in the acquisition, exploration, and evaluation of resource properties in Mexico. The company primarily explores for gold and copper deposits. It holds a 100% interest in the Las Minas project that consists of six mineral concessions located in the Las Minas district in the state of Veracruz, Mexico. Mexican Gold Mining Corp. was incorporated in 2006 and is based in Vancouver, Canada.Psyence Biomedical NASDAQ:PBM$2.36 -2.67 (-53.08%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.98 +1.63 (+68.86%) As of 08/1/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
